What is Neochild?
Neochild operates at the intersection of clinical safety and supply chain resilience, leveraging over four decades of expertise in neonatal and intravenous therapy. The company provides a comprehensive portfolio of medical devices, including safety enteral feeding systems, urinary catheters, and specialized IV extension sets. By prioritizing on-shore production and rigorous sterility standards, Neochild addresses the growing demand among hospitals and healthcare providers for reliable, high-quality clinical solutions that mitigate patient risk while optimizing operational costs.
How much funding has Neochild raised?
Neochild has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
Key Investors in Neochild
PPP
Public-Private Partnership
What's next for Neochild?
With the infusion of this latest financing, Neochild is well-positioned to scale its manufacturing capabilities and broaden its distribution footprint. The strategic focus will likely shift toward enhancing its custom convenience kits and deepening its integration into hospital procurement networks. As the company transitions through this Series B/C stage, the emphasis remains on maintaining supply chain integrity and driving innovation in pediatric patient care, ensuring that healthcare providers have access to the specialized tools necessary for high-acuity environments.
See full Neochild company page
